Bpifrance

Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.

Laurent Arthaud

Managing Director

Marion Aubry

Investment Director

Emmanuel Audouard

Director of Cross-Functional Investments Venture Capital

Elyssa Maufras du Châtellier

Investment Director

Charlotte Corbaz

Deputy Director of the Large Venture Fund and Deputy Managing Director

Sofia Dahoune

Associate

Vanessa Giraud

Managing Director

Laurent Higueret

Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund

Hortense Jacon

Investment Associate

Veronique Jacq

Head of Digital Venture team

So-Yeon Koo

Senior Investment Manager

Eric Lefebvre

Director

Arnaud Legardeur

Investment Director

Serge Mesguich

Director

Louis Molis

Investment Director

Adrien Neel

Investment Director

Gilles Schang

Deputy Director

Tuan Tran

Investment Director / VC

Past deals in 3D Printing

Healshape

Venture Round in 2022
Operator of a regenerative medicine company intended to develop breast regeneration alternatives by 3D bioprinting. The company develops a bioprosthesis for breast reconstruction, enabling women to regain their self-confidence through natural products and get long-lasting and aesthetic results after the surgery.

MyFit Solutions

Funding Round in 2021
MyFit Solutions develops SaaS entreprise software that provides 3D scanning solutions to make product size recommendation or tailor-made products.

Multiwave Imaging

Grant in 2020
Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

DNA Script

Series B in 2020
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Multiwave Imaging

Grant in 2020
Multiwave Imaging is a French company recognized as a leader in the design of metamaterial MRI antennas. It operates as a wholly owned subsidiary of Multiwave Technologies AG, which was founded in Switzerland in March 2015 and has its headquarters in Geneva. The company focuses on developing innovative metamaterial technologies aimed at enhancing quality of life. Multiwave Imaging's primary objective is to create and harness intellectual property, assess its commercial viability, and establish management teams to transform these innovations into marketable products. This strategic approach enables Multiwave Imaging to build companies across various sectors, leveraging advanced technology to address diverse needs.

Extrality

Seed Round in 2020
Extrality is a company based in Paris, France, that specializes in developing a platform for rapid numerical simulations using machine learning. Founded in 2019, the platform is designed to simplify artificial intelligence-driven simulations, enabling engineers to quickly evaluate the aerodynamics, fluid dynamics, and thermal properties of products. By maintaining essential physical accuracy, Extrality's technology supports manufacturers in sectors such as aerospace, transportation, and energy, allowing them to significantly decrease their time-to-market for new products.

Nfinite

Seed Round in 2019
nfinite is a Paris-based company founded in 2016 that operates a web platform connecting homeowners, architects, and designers to facilitate home customization. The platform leverages artificial intelligence and proprietary 3D technology to enhance the visual experience for online home and living businesses. In addition to customization services, nfinite also offers a range of products for sale, aiming to streamline the process of designing and purchasing homes.

DNA Script

Series B in 2019
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Lattice Medical

Seed Round in 2018
Lattice Medical is a medical technology company based in Loos, France, founded in 2017. The company specializes in the design and manufacture of innovative prostheses for women who have undergone mastectomy due to breast cancer. Its flagship product, MATTISSE, addresses significant clinical and societal needs by enabling natural breast reconstruction. MATTISSE uses a combination of biomaterials and tissue engineering, including 3D printing, to create custom implants that regenerate autologous adipose tissue. This technology allows for a single surgical procedure, as the fully biodegradable implants dissolve after reconstruction, minimizing invasiveness and pain while reducing surgery time. Lattice Medical aims to replace traditional silicone-based implants with its advanced solutions, thereby enhancing the quality of life for women affected by breast cancer.

DNA Script

Grant in 2018
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

DNA Script

Grant in 2018
DNA Script SAS, founded in 2014 and based in Paris, France, specializes in synthetic biology tools and innovative DNA synthesis technology. The company has developed a groundbreaking enzymatic technology that powers the SYNTAX, the world's first benchtop DNA printer. This device allows laboratories to produce synthetic oligonucleotides on-site, significantly enhancing workflow control and expediting access to results. By employing an efficient biochemical process for nucleic acid synthesis, DNA Script enables researchers to rapidly generate essential genomic materials, such as oligonucleotides, which are crucial for genomics and molecular biology applications. Through its advancements, DNA Script aims to facilitate breakthroughs in life sciences and human health.

Prodways

Venture Round in 2017
Prodways is a France-based company specializing in 3D printing solutions, offering a range of professional 3D printers and materials for various industries, including jewelry, footwear, industrial design, architecture, engineering, and automotive. The company is recognized for its capability to support series manufacturing, positioning itself as a credible alternative to leading global market players. Prodways operates through two main business segments: Products and Systems. The Systems segment encompasses various subsidiaries and services, while the Products segment includes a diverse array of specialized 3D printing solutions. By leveraging its complementary businesses, Prodways aims to provide a comprehensive suite of 3D printing services, making it a unique non-U.S. competitor in the market.

Innersense

Venture Round in 2017
They are 3D and AR experts, and they're fully dedicated to the furniture and home furnishing industry. Our technologies can be best described as sales support solutions for the industry professionals. Their partners and customers are now able to increase their sales by engaging their customers in their purchasing act, whether in store or directly at home.

Geomnia

Seed Round in 2015
Geomnia possesses specific know-how and core skills in 3D metrology, software engineering, micro and nano-scale mecatronics metrology systems engineering, and process optimization by software and measuring.

Usine IO

Seed Round in 2015
USINE IO is a Paris-based company that provides technical and consulting services tailored for inventors, start-ups, and established businesses. Founded in 2013, USINE IO facilitates the transition from idea to prototype, offering access to high-tech prototyping workshops and a co-working space. The company emphasizes industrialization preparation and provides a range of support services, including training and expert guidance in areas such as electronics, CAD, and design for manufacturing. With a commitment to fostering innovation, USINE IO operates without selection barriers, making its resources accessible to a wide array of clients.

3Dduo

Series A in 2014
3Dduo Sarl is a video game studio based in Tourcoing, France, founded in 2008. The company specializes in developing cross-media games, including serious games that convey important messages in an engaging manner, advergames for product promotion, and casual and social games for entertainment. With a focus on serving a diverse clientele, including customers, businesses, and government agencies, 3Dduo operates across various sectors such as healthcare, advertising, and education. The studio emphasizes interactive three-dimensional software and graphical environments, enabling users to experience enriched visual effects in online, interactive, and multiuser gaming environments.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.